At MD Anderson, we work in partnership with our patients to enable groundbreaking research to better prevent, diagnose and treat cancer. Grounded in a culture of collaboration, connectivity and data-based science, our research yields transformative findings that are shifting patient care and improving patients’ lives across the globe.
At the 2024 ASCO® Annual Meeting, our experts will showcase their pacesetting research and join colleagues for discussion on the latest advances in oncology.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open positions at MD Anderson.
Featured Podcast
"Phase I Research on DNA Damage"
Timothy Yap, M.B.B.S., Ph.D.
Professor
Investigational Cancer Therapeutics (Phase I Program)
Featured Articles
Proton therapy demonstrates advantages in Phase III head and neck cancer trial
Proton therapy achieved similar clinical outcomes while reducing malnutrition and feeding-tube dependency compared with traditional radiation therapy.
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
MD Anderson researchers share preliminary clinical data of an antibody drug conjugate for metastatic colorectal cancer and a USP1 inhibitor for advanced solid tumors.
MD Anderson Research Highlights: ASCO 2024 Special Edition
Featuring clinical trial results for leptomeningeal metastases, lymphoma and melanoma, biomarkers for anal cancer recurrence, and immunotherapy to prevent oral cancer
Meet the Experts
Visit MD Anderson at Booth 13069 to network with us, to ask a question, to learn about training and career opportunities and to continue the conversation on key presentations with our experts.
Saturday, June 1
11–11:30 a.m. CT
Tumor-Infiltrating Lymphocytes: The Latest Insights
Rodabe Amaria, M.D.
Professor, Melanoma Medical Oncology
Amir Jazaeri, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
1:30–2 p.m. CT
Goal Concordant Care
Kerin Adelson, M.D.
Chief Quality and Value Officer
Ryan Huey, M.D.
Assistant Professor, Gastrointestinal Medical Oncology
2–2:30 p.m. CT
Spotlight on Sarcoma
Anthony Conley, M.D.
Associate Professor, Sarcoma Medical Oncology
Ryan Denu, M.D., Ph.D.
Fellow, Cancer Medicine
Richard Gorlick, M.D.
Professor, Pediatrics Patient Care
3:30–4 p.m. CT
Focus on Physicians' Well-Being
Carin Hagberg, M.D.
Chief Academic Officer
Sunday, June 2
Monday, June 3
Our research by the numbers
$1.2B
invested in research
1,568
clinical trials
90
patents awarded
From Sept. 1, 2022 to Aug. 31, 2023
Why Houston?
As America's fourth-largest city, Houston has a lot to offer. Find out why Houston is a hub for scientific and medical excellence.
Breakthroughs in cancer treatment
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
MD Anderson News
